The Great Britain is witnessing a noticeable surge in interest surrounding entheogenic substances. Beyond the familiar use of psilocybin and LSD, investigators and explorers are increasingly exploring less-charted frontiers, particularly the copyright compound and the relatively new cannabinoid,